ACTIVE

DR. I. DEROOVER

Financial year 2025 · Closed on 31/12/2025

Net result29,3 k €+292,9 %over 1 year
Gross margin33,9 k €+275,9 %over 1 year
Equity216,9 k €+15,6 %over 1 year

Identity

Source · BCE/KBO

DR. I. DEROOVER is a Private company with limited liability incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Eeklo.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0808.702.460
Incorporation
24/12/2008
Legal form
Private company with limited liability
Registered office
Antwerpse Heirweg 16 B
9900 Eeklo · FlandreSee on map
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 17 filings

Trend over 17 financial years

20252024202320222021
Income statement
Gross margin33,9 k €-19,2 k €27,3 k €42,2 k €-126 k €
EBITDA32,3 k €-21,4 k €25,5 k €40,5 k €-127,7 k €
Operating result27,9 k €-21,7 k €25,2 k €40,2 k €-128,2 k €
Net result29,3 k €-15,2 k €27 k €30,1 k €-129 k €
Balance sheet
Equity216,9 k €187,6 k €202,8 k €175,8 k €145,7 k €
Total assets319,2 k €326,3 k €401,8 k €381,9 k €394,8 k €
Cash240,6 k €276,6 k €150,6 k €316,1 k €327,4 k €
Debts102,2 k €138,7 k €198,9 k €206,1 k €248 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

INGE DEROOVER

Director · since 22 décembre 2008

Active

Ended mandates

Inge Deroover

Mandate

Ended
Inge Deroover

Director

Ended
Inge Deroover

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date19/06/202614/07/202501/07/202428/06/202330/06/202209/07/2021
General meeting14/06/202630/06/202527/06/202420/06/202327/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 17 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202514/06/202619/06/2026DutchPDF
Micro model31/12/202430/06/202514/07/2025DutchPDF
Micro model31/12/202327/06/202401/07/2024DutchPDF
Micro model31/12/202220/06/202328/06/2023DutchPDF
Micro model31/12/202127/06/202230/06/2022DutchPDF
Micro model31/12/202030/06/202109/07/2021DutchPDF
Micro model31/12/201918/06/202007/07/2020DutchPDF
Micro model31/12/201831/07/201929/08/2019DutchPDF
Micro model31/12/201730/06/201820/07/2018DutchPDF
Micro model31/12/201630/06/201714/07/2017DutchPDF
Abridged model31/12/201530/06/201630/08/2016DutchPDF
Abridged model31/12/201414/04/201524/07/2015DutchPDF
Abridged model31/12/201315/04/201429/08/2014DutchPDF
Abridged model31/12/201215/04/201327/08/2013DutchPDF
Abridged model31/12/201130/06/201231/08/2012DutchPDF
Abridged model31/12/201030/06/201116/08/2011DutchPDF
Abridged model31/12/200915/04/201031/08/2010DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

INGE DEROOVER

Director · since 22 décembre 2008

Active

Ended mandates

Inge Deroover

Mandate

Ended
Inge Deroover

Director

Ended
Inge Deroover

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other07/01/2010
    DIVERSEN
    PDF
  • Other06/01/2009
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202529,3 k €↑
  2. 2024
    Annual accounts 2024-15,2 k €↓
  3. 2023
    Annual accounts 202327 k €↓
  4. 2022
    Annual accounts 202230,1 k €↑
  5. 2021
    Annual accounts 2021-129 k €↓
  6. 2021
    Name changeDR. DEROOVER I.
  7. 2020
    Annual accounts 202028,9 k €↓
  8. 2019
    Annual accounts 201960,7 k €↓
  9. 2018
    Annual accounts 201864,2 k €↑
  10. 2017
    Annual accounts 201728,8 k €↑
  11. 2016
    Annual accounts 201614,4 k €↑
  12. 2015
    Annual accounts 20151,2 k €↓
  13. 2014
    Annual accounts 201467,5 k €↑
  14. 2013
    Annual accounts 2013-12,1 k €↓
  15. 2012
    Annual accounts 201258,5 k €↑
  16. 2011
    Annual accounts 201137,3 k €↓
  17. 2010
    Annual accounts 201046,1 k €↓
  18. 2009
    Annual accounts 200997 k €
  19. 2009
    Name changeDR. I. DEROOVER
  20. 24/12/2008
    IncorporationPrivate company with limited liability